156 related articles for article (PubMed ID: 8771166)
1. Vincristine therapy for children with acute lymphoblastic leukemia impairs conduction in the entire peripheral nerve.
Vainionpää L; Kovala T; Tolonen U; Lanning M
Pediatr Neurol; 1995 Nov; 13(4):314-8. PubMed ID: 8771166
[TBL] [Abstract][Full Text] [Related]
2. Nerve lesions after therapy for childhood acute lymphoblastic leukemia.
Harila-Saari AH; Vainionpää LK; Kovala TT; Tolonen EU; Lanning BM
Cancer; 1998 Jan; 82(1):200-7. PubMed ID: 9428498
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials.
Vainionpää L; Kovala T; Tolonen U; Lanning M
Med Pediatr Oncol; 1997 Jan; 28(1):41-7. PubMed ID: 8950335
[TBL] [Abstract][Full Text] [Related]
4. Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement.
Nazir HF; AlFutaisi A; Zacharia M; Elshinawy M; Mevada ST; Alrawas A; Khater D; Jaju D; Wali Y
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28623857
[TBL] [Abstract][Full Text] [Related]
5. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
Reinders-Messelink HA; Van Weerden TW; Fock JM; Gidding CE; Vingerhoets HM; Schoemaker MM; Göeken LN; Bökkerink JP; Kamps WA
Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069
[TBL] [Abstract][Full Text] [Related]
6. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
[No Abstract] [Full Text] [Related]
7. Vincristine-related neuropathy versus acute inflammatory demyelinating polyradiculoneuropathy in children with acute lymphoblastic leukemia.
Brigo F; Balter R; Marradi P; Ferlisi M; Zaccaron A; Fiaschi A; Frasson E; Bertolasi L
J Child Neurol; 2012 Jul; 27(7):867-74. PubMed ID: 22241706
[TBL] [Abstract][Full Text] [Related]
8. Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics.
Jain P; Gulati S; Seth R; Bakhshi S; Toteja GS; Pandey RM
J Child Neurol; 2014 Jul; 29(7):932-7. PubMed ID: 23781018
[TBL] [Abstract][Full Text] [Related]
9. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
[TBL] [Abstract][Full Text] [Related]
10. Vincristine-induced vocal cord palsy: case report and review of the literature.
Latiff ZA; Kamal NA; Jahendran J; Alias H; Goh BS; Syed Zakaria SZ; Jamal R
J Pediatr Hematol Oncol; 2010 Jul; 32(5):407-10. PubMed ID: 20505534
[TBL] [Abstract][Full Text] [Related]
11. Vincristine neurotoxicity in the presence of hereditary neuropathy.
Trobaugh-Lotrario AD; Smith AA; Odom LF
Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
[No Abstract] [Full Text] [Related]
12. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
13. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
[TBL] [Abstract][Full Text] [Related]
14. Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials.
Harila-Saari AH; Huuskonen UE; Tolonen U; Vainionpää LK; Lanning BM
Med Pediatr Oncol; 2001 Mar; 36(3):345-51. PubMed ID: 11241435
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological Studies to Detect Peripheral Neuropathy in Children Treated With Vincristine.
Kavcic M; Koritnik B; Krzan M; Velikonja O; Prelog T; Stefanovic M; Debeljak M; Jazbec J
J Pediatr Hematol Oncol; 2017 May; 39(4):266-271. PubMed ID: 28375940
[TBL] [Abstract][Full Text] [Related]
16. Acute sixth-nerve palsy after vincristine therapy.
Lash SC; Williams CP; Marsh CS; Crithchley C; Hodgkins PR; Mackie EJ
J AAPOS; 2004 Feb; 8(1):67-8. PubMed ID: 14970803
[TBL] [Abstract][Full Text] [Related]
17. Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia.
Mantadakis E; Amoiridis G; Kondi A; Kalmanti M
J Pediatr Hematol Oncol; 2007 Feb; 29(2):130. PubMed ID: 17279013
[No Abstract] [Full Text] [Related]
18. Severe Vincristine-related Neurotoxicity in 5 Patients With Pediatric Acute Lymphoblastic Leukemia Requiring Discontinuation of Vincristine: A Description of Long-term Outcome.
Egan-Sherry D; Bhuta R; Cole PD; Gennarini LM; Kahn JM; Sulis ML; DeNardo BD; Welch JJG
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e997-e999. PubMed ID: 34001785
[TBL] [Abstract][Full Text] [Related]
19. RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN.
Tunjungsari DA; Gunawan PI; Ugrasena IDG
J Med Invest; 2021; 68(3.4):232-237. PubMed ID: 34759136
[TBL] [Abstract][Full Text] [Related]
20. Incidence of vincristine induced neurotoxicity in children with acute lymphoblastic leukemia and its correlation with nutritional deficiencies.
Dudeja S; Gupta S; Sharma S; Jain A; Sharma S; Jain P; Aneja S; Chandra J
Pediatr Hematol Oncol; 2019 Sep; 36(6):344-351. PubMed ID: 31514565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]